Bolivian hemorrhagic fever outbreaks began in 1959 and continued throughout the early 1960s in rural regions across Bolivia, particularly the Beni region bordering San Joaquin near Bolivia’s eastern border. The quick spread of the illness and the horrible deaths of peasants in San Joaquin sparked widespread alarm, causing Bolivian authorities to seek assistance from US specialists. Following months of inquiry, the US authorities identified the Machupo virus, a member of the Arenavirus family, as the source of the outbreaks.
Bolivians meant the mysterious illness “Black Typhus,” about the hemorrhaging, high fever, discomfort, and quick demise it was known to induce. Contact with infected rodents’ urine, saliva, or feces urine, saliva, or feces of infected rodents—primarily the Calomys callous genera, commonly called the Bolivian or black-capped rice rat—transmits the virus to people. Direct contact with bodily fluids that are infected can also result in human-to-human transmission. Machupo virus exposure causes asymptomatic infection with virus shedding in saliva, urine, and feces; 30-50% of clinically infected C. callosus remain chronically viremic and release the virus in body excretions or secretions.
Although the infectious level of Machupo virus among humans is unknown, exposed people may get infected by breathing in the virus shed in aerosolized fluids or excretions of plagued rodents, consuming food poisoned with rodent excreta (thus resulting in a foodborne illness) or coming into direct contact with excreta on broken skin or oropharyngeal surfaces.
The epidemiology of the Machupo virus is characterized by sporadic outbreaks occurring in rural areas, particularly among individuals involved in agriculture, farming, or other occupations that push them into close contact with rodents. The virus is endemic to some areas of Bolivia, with occasional cases reported in neighboring countries such as Brazil and Argentina.
Karl Johnson at the NIH designed a portable laboratory glove container to keep experimental mice under sterile circumstances so that the disease could be studied in rural Bolivia. Several virologists fell ill during the identification procedure, and the epidemic claimed the lives of about 20% of the San Joaquin hamlet population. Since then, isolated cases of the endemic Machupo virus have been reported in rural eastern & northern Bolivia.
The incidence of Machupo virus infection is relatively low compared to other viral hemorrhagic fevers. However, depending on the epidemic and the standard of medical care, the disease inflicts severe mortality and morbidity, and fatal cases range from 8% to 30%.
Kingdom: Virus
Phylum: Negarnaviricota
Class: Ellioviricetes
Order: Bunyavirales
Family: Arenaviridae
Genus:Mammarenavirus
Species: Machupo virus
Machupo virus particles exhibit a pleomorphic or variable shape. They can appear as spherical or filamentous structures. Size is approximately 100-300 nm in diameter.
The RNA genome of the Machupo virus is tightly associated with viral proteins, forming ribonucleoprotein complexes (RNPs). These RNPs are essential for viral replication and transcription of viral RNA.
The genome of the Machupo virus consists of two segments of negative-sense, single-stranded RNA. These RNA segments, L (large) and S (small) encode the viral proteins necessary for replication and virion assembly.
There are no antigenic types of the Machupo virus. Machupo virus is a single serotype. It means that all Machupo virus particles have the same antigens on their surface.
The lipid bilayer of the Machupo virus contains glycoproteins that act as antigens. These glycoproteins are responsible for the immune response to Machupo virus infection. The lack of antigenic types of the Machupo virus makes it difficult to develop vaccines against the virus.
Machupo virus (MACV) enters host cells by utilizing its GP1 attachment glycoprotein, which binds to a cellular receptor called transferrin receptor 1 (TfR1). TfR1 is a membrane protein involved in iron transport and is present on the surface of many cell types. The binding of MACV GP1 to TfR1 is crucial for entering the virus into host cells. Specific residues on TfR1 have been identified as essential for interacting with MACV GP1. These residues provide binding sites for the viral glycoprotein, allowing the virus to attach to the cell surface.
Additionally, a co-crystal structure of MACV GP1 bound to TfR1 has been obtained, providing valuable insights into the molecular details of this interaction. The co-crystal structure helps identify specific GP1 residues essential for the association with TfR1, shedding light on the molecular basis of the virus-receptor interaction.
The viral RNA is a template for synthesizing viral proteins and replicating the viral genome. MACV replicates primarily in endothelial cells, macrophages, and other immune cells, leading to a systemic infection.
MACV infection can cause widespread damage to various organs, particularly the vascular system. It can result in increased vascular permeability, bleeding, and organ dysfunction. The clinical manifestations of MACV infection can include fever, headache, malaise, myalgia, and bleeding tendencies.
Innate immune response:
It includes physical barriers like mucous membranes & skin and immune cells like macrophages & natural killer cells. Macrophages can recognize and engulf MACV-infected cells, while NK cells can kill virus-infected cells.
Infected cells produce and secrete interferons in response to viral infection, including MACV. They serve as alarm signals, alerting neighboring cells to the presence of the virus. Interferons bind to specific receptors on neighboring cells, triggering cellular responses that collectively create an antiviral state. This state prepares the cells to defend against MACV infection and restrict replication.
Antiviral Signaling Pathways:
RIG-I-like receptor (RLR) pathway: RLRs are a group of pattern recognition receptors (PRRs) found within the cytoplasm of host cells. They can detect viral RNA, including that of MACV, and initiate an immune response. The main RLR involved in response to MACV is called RIG-I (Retinoic acid-inducible gene I). Upon recognition of viral RNA, RIG-I undergoes a conformational change, leading to its activation. Activated RIG-I then binds to a protein called MAVS (mitochondrial antiviral signaling) in the mitochondria, triggering a cascade of signaling events. It produces type I interferons (IFNs) and pro-inflammatory cytokines, which have antiviral properties and help limit MACV replication.
Toll-like receptor (TLR) pathway: Toll-like receptors are another group of PRRs on the surface or within endosomes of host cells. TLRs can recognize specific molecular patterns associated with pathogens, including viruses. TLR3 and TLR7 are essential in recognizing viral RNA, including MACV RNA.
Machupo virus is the causative agent of Bolivian hemorrhagic fever (BHF), a severe and potentially life-threatening disease. The disease is primarily found in Bolivia, particularly in rural areas, and is associated with significant morbidity and mortality. The clinical manifestations can vary but commonly include the following:
Initial Symptoms: The incubation period for Machupo virus infection ranges from 7 to 21 days. The primary symptoms are nonspecific and may include fever, headache, malaise, muscle aches, joint pain, and fatigue. Like many other viral infections, these symptoms can make early diagnosis challenging.
Hemorrhagic Manifestations: Patients may develop hemorrhagic manifestations as the disease progresses. These can include bleeding from the gums, nose, or other mucous membranes, bruising, petechiae (small red or purple spots on the skin), and ecchymosis (more extensive areas of bleeding under the skin). Hemorrhage can also occur internally, leading to gastrointestinal bleeding, hematuria (blood in the urine), and other forms of internal bleeding.
Organ Dysfunction: The Machupo virus can cause multiple organ dysfunction, including liver, kidney, and cardiovascular system involvement. Hepatitis (liver inflammation) with elevated liver enzymes and jaundice (yellowing of your skin & eyes) are frequent symptoms. Kidney dysfunction can manifest as proteinuria (the presence of protein in the urine) and decreased urine output. Cardiovascular complications may include low blood pressure (hypotension) and shock.
Neurological Symptoms:Machupo virus infection can affect the central nervous system, leading to neurological symptoms in severe cases. These can include confusion, disorientation, seizures, coma, and focal neurological deficits. Meningitis (swelling of the membranes encircling the spinal cord & brain) and encephalitis (swelling of the brain) have been reported in some cases.
Respiratory Distress: In extreme cases, respiratory symptoms like wheezing, shortness of breath, and thoracic discomfort might occur. Pneumonia & a condition called acute respiratory distress syndrome are two conditions that may develop, leading to respiratory failure.
Antigen Detection ELISA: In this assay, a specific antibody that recognizes the viral antigen of the Machupo virus is immobilized on a solid surface, such as a microplate. The patient sample, which may be serum, plasma, or other body fluids, is added to the plate. If the sample contains Machupo virus antigens, they will bind to the immobilized antibody. This binding is detected using an enzyme-conjugated secondary antibody that recognizes and binds to the viral antigens. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating a positive result for Machupo virus infection.
IgM Antibody Detection ELISA: During the early stage of Machupo virus infection, the immune system produces specific IgM antibodies in response to the viral presence. In this ELISA, the viral antigen is immobilized on a solid surface. The patient sample is added to the plate, and if it contains Machupo virus-specific IgM antibodies, they will bind to the immobilized antigen. An enzyme-conjugated anti-human IgM antibody is then added, binding to the IgM antibodies in the sample. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating the presence of Machupo virus-specific IgM antibodies.
RT-PCR tests: These involve the extraction of viral RNA from a clinical sample, such as blood or tissue, followed by reverse transcription, which converts the viral RNA into complementary DNA (cDNA). The cDNA is then amplified using specific primers targeting regions of the Machupo virus genome. If the Machupo virus RNA is present in the sample, the amplification will produce specific DNA fragments that can be detected and analyzed.
The primary reservoir of the Machupo virus is the Calomys callosus rodent, commonly known as the Bolivian or black-capped rice rat. Implementing effective rodent control measures, such as maintaining clean living environments, sealing entry points, and using rodenticides, can help reduce the risk of human exposure to infected rodents.
Proper hygiene practices can help minimize the risk of Machupo virus exposure. These practices include washing your hands, avoiding contact with ill people, and enclosing your mouth & nose during coughing or sneezing.
When working in areas where the Machupo virus is found, wearing personal protective equipment (PPE) is essential. PPE includes gloves, goggles, and a mask. PPE can help to protect you from exposure to the virus.
There is a vaccine available for the Machupo virus. This vaccine is effective in preventing Bolivian hemorrhagic fever.
Bolivian hemorrhagic fever outbreaks began in 1959 and continued throughout the early 1960s in rural regions across Bolivia, particularly the Beni region bordering San Joaquin near Bolivia’s eastern border. The quick spread of the illness and the horrible deaths of peasants in San Joaquin sparked widespread alarm, causing Bolivian authorities to seek assistance from US specialists. Following months of inquiry, the US authorities identified the Machupo virus, a member of the Arenavirus family, as the source of the outbreaks.
Bolivians meant the mysterious illness “Black Typhus,” about the hemorrhaging, high fever, discomfort, and quick demise it was known to induce. Contact with infected rodents’ urine, saliva, or feces urine, saliva, or feces of infected rodents—primarily the Calomys callous genera, commonly called the Bolivian or black-capped rice rat—transmits the virus to people. Direct contact with bodily fluids that are infected can also result in human-to-human transmission. Machupo virus exposure causes asymptomatic infection with virus shedding in saliva, urine, and feces; 30-50% of clinically infected C. callosus remain chronically viremic and release the virus in body excretions or secretions.
Although the infectious level of Machupo virus among humans is unknown, exposed people may get infected by breathing in the virus shed in aerosolized fluids or excretions of plagued rodents, consuming food poisoned with rodent excreta (thus resulting in a foodborne illness) or coming into direct contact with excreta on broken skin or oropharyngeal surfaces.
The epidemiology of the Machupo virus is characterized by sporadic outbreaks occurring in rural areas, particularly among individuals involved in agriculture, farming, or other occupations that push them into close contact with rodents. The virus is endemic to some areas of Bolivia, with occasional cases reported in neighboring countries such as Brazil and Argentina.
Karl Johnson at the NIH designed a portable laboratory glove container to keep experimental mice under sterile circumstances so that the disease could be studied in rural Bolivia. Several virologists fell ill during the identification procedure, and the epidemic claimed the lives of about 20% of the San Joaquin hamlet population. Since then, isolated cases of the endemic Machupo virus have been reported in rural eastern & northern Bolivia.
The incidence of Machupo virus infection is relatively low compared to other viral hemorrhagic fevers. However, depending on the epidemic and the standard of medical care, the disease inflicts severe mortality and morbidity, and fatal cases range from 8% to 30%.
Kingdom: Virus
Phylum: Negarnaviricota
Class: Ellioviricetes
Order: Bunyavirales
Family: Arenaviridae
Genus:Mammarenavirus
Species: Machupo virus
Machupo virus particles exhibit a pleomorphic or variable shape. They can appear as spherical or filamentous structures. Size is approximately 100-300 nm in diameter.
The RNA genome of the Machupo virus is tightly associated with viral proteins, forming ribonucleoprotein complexes (RNPs). These RNPs are essential for viral replication and transcription of viral RNA.
The genome of the Machupo virus consists of two segments of negative-sense, single-stranded RNA. These RNA segments, L (large) and S (small) encode the viral proteins necessary for replication and virion assembly.
There are no antigenic types of the Machupo virus. Machupo virus is a single serotype. It means that all Machupo virus particles have the same antigens on their surface.
The lipid bilayer of the Machupo virus contains glycoproteins that act as antigens. These glycoproteins are responsible for the immune response to Machupo virus infection. The lack of antigenic types of the Machupo virus makes it difficult to develop vaccines against the virus.
Machupo virus (MACV) enters host cells by utilizing its GP1 attachment glycoprotein, which binds to a cellular receptor called transferrin receptor 1 (TfR1). TfR1 is a membrane protein involved in iron transport and is present on the surface of many cell types. The binding of MACV GP1 to TfR1 is crucial for entering the virus into host cells. Specific residues on TfR1 have been identified as essential for interacting with MACV GP1. These residues provide binding sites for the viral glycoprotein, allowing the virus to attach to the cell surface.
Additionally, a co-crystal structure of MACV GP1 bound to TfR1 has been obtained, providing valuable insights into the molecular details of this interaction. The co-crystal structure helps identify specific GP1 residues essential for the association with TfR1, shedding light on the molecular basis of the virus-receptor interaction.
The viral RNA is a template for synthesizing viral proteins and replicating the viral genome. MACV replicates primarily in endothelial cells, macrophages, and other immune cells, leading to a systemic infection.
MACV infection can cause widespread damage to various organs, particularly the vascular system. It can result in increased vascular permeability, bleeding, and organ dysfunction. The clinical manifestations of MACV infection can include fever, headache, malaise, myalgia, and bleeding tendencies.
Innate immune response:
It includes physical barriers like mucous membranes & skin and immune cells like macrophages & natural killer cells. Macrophages can recognize and engulf MACV-infected cells, while NK cells can kill virus-infected cells.
Infected cells produce and secrete interferons in response to viral infection, including MACV. They serve as alarm signals, alerting neighboring cells to the presence of the virus. Interferons bind to specific receptors on neighboring cells, triggering cellular responses that collectively create an antiviral state. This state prepares the cells to defend against MACV infection and restrict replication.
Antiviral Signaling Pathways:
RIG-I-like receptor (RLR) pathway: RLRs are a group of pattern recognition receptors (PRRs) found within the cytoplasm of host cells. They can detect viral RNA, including that of MACV, and initiate an immune response. The main RLR involved in response to MACV is called RIG-I (Retinoic acid-inducible gene I). Upon recognition of viral RNA, RIG-I undergoes a conformational change, leading to its activation. Activated RIG-I then binds to a protein called MAVS (mitochondrial antiviral signaling) in the mitochondria, triggering a cascade of signaling events. It produces type I interferons (IFNs) and pro-inflammatory cytokines, which have antiviral properties and help limit MACV replication.
Toll-like receptor (TLR) pathway: Toll-like receptors are another group of PRRs on the surface or within endosomes of host cells. TLRs can recognize specific molecular patterns associated with pathogens, including viruses. TLR3 and TLR7 are essential in recognizing viral RNA, including MACV RNA.
Machupo virus is the causative agent of Bolivian hemorrhagic fever (BHF), a severe and potentially life-threatening disease. The disease is primarily found in Bolivia, particularly in rural areas, and is associated with significant morbidity and mortality. The clinical manifestations can vary but commonly include the following:
Initial Symptoms: The incubation period for Machupo virus infection ranges from 7 to 21 days. The primary symptoms are nonspecific and may include fever, headache, malaise, muscle aches, joint pain, and fatigue. Like many other viral infections, these symptoms can make early diagnosis challenging.
Hemorrhagic Manifestations: Patients may develop hemorrhagic manifestations as the disease progresses. These can include bleeding from the gums, nose, or other mucous membranes, bruising, petechiae (small red or purple spots on the skin), and ecchymosis (more extensive areas of bleeding under the skin). Hemorrhage can also occur internally, leading to gastrointestinal bleeding, hematuria (blood in the urine), and other forms of internal bleeding.
Organ Dysfunction: The Machupo virus can cause multiple organ dysfunction, including liver, kidney, and cardiovascular system involvement. Hepatitis (liver inflammation) with elevated liver enzymes and jaundice (yellowing of your skin & eyes) are frequent symptoms. Kidney dysfunction can manifest as proteinuria (the presence of protein in the urine) and decreased urine output. Cardiovascular complications may include low blood pressure (hypotension) and shock.
Neurological Symptoms:Machupo virus infection can affect the central nervous system, leading to neurological symptoms in severe cases. These can include confusion, disorientation, seizures, coma, and focal neurological deficits. Meningitis (swelling of the membranes encircling the spinal cord & brain) and encephalitis (swelling of the brain) have been reported in some cases.
Respiratory Distress: In extreme cases, respiratory symptoms like wheezing, shortness of breath, and thoracic discomfort might occur. Pneumonia & a condition called acute respiratory distress syndrome are two conditions that may develop, leading to respiratory failure.
Antigen Detection ELISA: In this assay, a specific antibody that recognizes the viral antigen of the Machupo virus is immobilized on a solid surface, such as a microplate. The patient sample, which may be serum, plasma, or other body fluids, is added to the plate. If the sample contains Machupo virus antigens, they will bind to the immobilized antibody. This binding is detected using an enzyme-conjugated secondary antibody that recognizes and binds to the viral antigens. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating a positive result for Machupo virus infection.
IgM Antibody Detection ELISA: During the early stage of Machupo virus infection, the immune system produces specific IgM antibodies in response to the viral presence. In this ELISA, the viral antigen is immobilized on a solid surface. The patient sample is added to the plate, and if it contains Machupo virus-specific IgM antibodies, they will bind to the immobilized antigen. An enzyme-conjugated anti-human IgM antibody is then added, binding to the IgM antibodies in the sample. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating the presence of Machupo virus-specific IgM antibodies.
RT-PCR tests: These involve the extraction of viral RNA from a clinical sample, such as blood or tissue, followed by reverse transcription, which converts the viral RNA into complementary DNA (cDNA). The cDNA is then amplified using specific primers targeting regions of the Machupo virus genome. If the Machupo virus RNA is present in the sample, the amplification will produce specific DNA fragments that can be detected and analyzed.
The primary reservoir of the Machupo virus is the Calomys callosus rodent, commonly known as the Bolivian or black-capped rice rat. Implementing effective rodent control measures, such as maintaining clean living environments, sealing entry points, and using rodenticides, can help reduce the risk of human exposure to infected rodents.
Proper hygiene practices can help minimize the risk of Machupo virus exposure. These practices include washing your hands, avoiding contact with ill people, and enclosing your mouth & nose during coughing or sneezing.
When working in areas where the Machupo virus is found, wearing personal protective equipment (PPE) is essential. PPE includes gloves, goggles, and a mask. PPE can help to protect you from exposure to the virus.
There is a vaccine available for the Machupo virus. This vaccine is effective in preventing Bolivian hemorrhagic fever.
Bolivian hemorrhagic fever outbreaks began in 1959 and continued throughout the early 1960s in rural regions across Bolivia, particularly the Beni region bordering San Joaquin near Bolivia’s eastern border. The quick spread of the illness and the horrible deaths of peasants in San Joaquin sparked widespread alarm, causing Bolivian authorities to seek assistance from US specialists. Following months of inquiry, the US authorities identified the Machupo virus, a member of the Arenavirus family, as the source of the outbreaks.
Bolivians meant the mysterious illness “Black Typhus,” about the hemorrhaging, high fever, discomfort, and quick demise it was known to induce. Contact with infected rodents’ urine, saliva, or feces urine, saliva, or feces of infected rodents—primarily the Calomys callous genera, commonly called the Bolivian or black-capped rice rat—transmits the virus to people. Direct contact with bodily fluids that are infected can also result in human-to-human transmission. Machupo virus exposure causes asymptomatic infection with virus shedding in saliva, urine, and feces; 30-50% of clinically infected C. callosus remain chronically viremic and release the virus in body excretions or secretions.
Although the infectious level of Machupo virus among humans is unknown, exposed people may get infected by breathing in the virus shed in aerosolized fluids or excretions of plagued rodents, consuming food poisoned with rodent excreta (thus resulting in a foodborne illness) or coming into direct contact with excreta on broken skin or oropharyngeal surfaces.
The epidemiology of the Machupo virus is characterized by sporadic outbreaks occurring in rural areas, particularly among individuals involved in agriculture, farming, or other occupations that push them into close contact with rodents. The virus is endemic to some areas of Bolivia, with occasional cases reported in neighboring countries such as Brazil and Argentina.
Karl Johnson at the NIH designed a portable laboratory glove container to keep experimental mice under sterile circumstances so that the disease could be studied in rural Bolivia. Several virologists fell ill during the identification procedure, and the epidemic claimed the lives of about 20% of the San Joaquin hamlet population. Since then, isolated cases of the endemic Machupo virus have been reported in rural eastern & northern Bolivia.
The incidence of Machupo virus infection is relatively low compared to other viral hemorrhagic fevers. However, depending on the epidemic and the standard of medical care, the disease inflicts severe mortality and morbidity, and fatal cases range from 8% to 30%.
Kingdom: Virus
Phylum: Negarnaviricota
Class: Ellioviricetes
Order: Bunyavirales
Family: Arenaviridae
Genus:Mammarenavirus
Species: Machupo virus
Machupo virus particles exhibit a pleomorphic or variable shape. They can appear as spherical or filamentous structures. Size is approximately 100-300 nm in diameter.
The RNA genome of the Machupo virus is tightly associated with viral proteins, forming ribonucleoprotein complexes (RNPs). These RNPs are essential for viral replication and transcription of viral RNA.
The genome of the Machupo virus consists of two segments of negative-sense, single-stranded RNA. These RNA segments, L (large) and S (small) encode the viral proteins necessary for replication and virion assembly.
There are no antigenic types of the Machupo virus. Machupo virus is a single serotype. It means that all Machupo virus particles have the same antigens on their surface.
The lipid bilayer of the Machupo virus contains glycoproteins that act as antigens. These glycoproteins are responsible for the immune response to Machupo virus infection. The lack of antigenic types of the Machupo virus makes it difficult to develop vaccines against the virus.
Machupo virus (MACV) enters host cells by utilizing its GP1 attachment glycoprotein, which binds to a cellular receptor called transferrin receptor 1 (TfR1). TfR1 is a membrane protein involved in iron transport and is present on the surface of many cell types. The binding of MACV GP1 to TfR1 is crucial for entering the virus into host cells. Specific residues on TfR1 have been identified as essential for interacting with MACV GP1. These residues provide binding sites for the viral glycoprotein, allowing the virus to attach to the cell surface.
Additionally, a co-crystal structure of MACV GP1 bound to TfR1 has been obtained, providing valuable insights into the molecular details of this interaction. The co-crystal structure helps identify specific GP1 residues essential for the association with TfR1, shedding light on the molecular basis of the virus-receptor interaction.
The viral RNA is a template for synthesizing viral proteins and replicating the viral genome. MACV replicates primarily in endothelial cells, macrophages, and other immune cells, leading to a systemic infection.
MACV infection can cause widespread damage to various organs, particularly the vascular system. It can result in increased vascular permeability, bleeding, and organ dysfunction. The clinical manifestations of MACV infection can include fever, headache, malaise, myalgia, and bleeding tendencies.
Innate immune response:
It includes physical barriers like mucous membranes & skin and immune cells like macrophages & natural killer cells. Macrophages can recognize and engulf MACV-infected cells, while NK cells can kill virus-infected cells.
Infected cells produce and secrete interferons in response to viral infection, including MACV. They serve as alarm signals, alerting neighboring cells to the presence of the virus. Interferons bind to specific receptors on neighboring cells, triggering cellular responses that collectively create an antiviral state. This state prepares the cells to defend against MACV infection and restrict replication.
Antiviral Signaling Pathways:
RIG-I-like receptor (RLR) pathway: RLRs are a group of pattern recognition receptors (PRRs) found within the cytoplasm of host cells. They can detect viral RNA, including that of MACV, and initiate an immune response. The main RLR involved in response to MACV is called RIG-I (Retinoic acid-inducible gene I). Upon recognition of viral RNA, RIG-I undergoes a conformational change, leading to its activation. Activated RIG-I then binds to a protein called MAVS (mitochondrial antiviral signaling) in the mitochondria, triggering a cascade of signaling events. It produces type I interferons (IFNs) and pro-inflammatory cytokines, which have antiviral properties and help limit MACV replication.
Toll-like receptor (TLR) pathway: Toll-like receptors are another group of PRRs on the surface or within endosomes of host cells. TLRs can recognize specific molecular patterns associated with pathogens, including viruses. TLR3 and TLR7 are essential in recognizing viral RNA, including MACV RNA.
Machupo virus is the causative agent of Bolivian hemorrhagic fever (BHF), a severe and potentially life-threatening disease. The disease is primarily found in Bolivia, particularly in rural areas, and is associated with significant morbidity and mortality. The clinical manifestations can vary but commonly include the following:
Initial Symptoms: The incubation period for Machupo virus infection ranges from 7 to 21 days. The primary symptoms are nonspecific and may include fever, headache, malaise, muscle aches, joint pain, and fatigue. Like many other viral infections, these symptoms can make early diagnosis challenging.
Hemorrhagic Manifestations: Patients may develop hemorrhagic manifestations as the disease progresses. These can include bleeding from the gums, nose, or other mucous membranes, bruising, petechiae (small red or purple spots on the skin), and ecchymosis (more extensive areas of bleeding under the skin). Hemorrhage can also occur internally, leading to gastrointestinal bleeding, hematuria (blood in the urine), and other forms of internal bleeding.
Organ Dysfunction: The Machupo virus can cause multiple organ dysfunction, including liver, kidney, and cardiovascular system involvement. Hepatitis (liver inflammation) with elevated liver enzymes and jaundice (yellowing of your skin & eyes) are frequent symptoms. Kidney dysfunction can manifest as proteinuria (the presence of protein in the urine) and decreased urine output. Cardiovascular complications may include low blood pressure (hypotension) and shock.
Neurological Symptoms:Machupo virus infection can affect the central nervous system, leading to neurological symptoms in severe cases. These can include confusion, disorientation, seizures, coma, and focal neurological deficits. Meningitis (swelling of the membranes encircling the spinal cord & brain) and encephalitis (swelling of the brain) have been reported in some cases.
Respiratory Distress: In extreme cases, respiratory symptoms like wheezing, shortness of breath, and thoracic discomfort might occur. Pneumonia & a condition called acute respiratory distress syndrome are two conditions that may develop, leading to respiratory failure.
Antigen Detection ELISA: In this assay, a specific antibody that recognizes the viral antigen of the Machupo virus is immobilized on a solid surface, such as a microplate. The patient sample, which may be serum, plasma, or other body fluids, is added to the plate. If the sample contains Machupo virus antigens, they will bind to the immobilized antibody. This binding is detected using an enzyme-conjugated secondary antibody that recognizes and binds to the viral antigens. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating a positive result for Machupo virus infection.
IgM Antibody Detection ELISA: During the early stage of Machupo virus infection, the immune system produces specific IgM antibodies in response to the viral presence. In this ELISA, the viral antigen is immobilized on a solid surface. The patient sample is added to the plate, and if it contains Machupo virus-specific IgM antibodies, they will bind to the immobilized antigen. An enzyme-conjugated anti-human IgM antibody is then added, binding to the IgM antibodies in the sample. Adding a substrate for the enzyme leads to the developing of a colored or fluorescent signal, indicating the presence of Machupo virus-specific IgM antibodies.
RT-PCR tests: These involve the extraction of viral RNA from a clinical sample, such as blood or tissue, followed by reverse transcription, which converts the viral RNA into complementary DNA (cDNA). The cDNA is then amplified using specific primers targeting regions of the Machupo virus genome. If the Machupo virus RNA is present in the sample, the amplification will produce specific DNA fragments that can be detected and analyzed.
The primary reservoir of the Machupo virus is the Calomys callosus rodent, commonly known as the Bolivian or black-capped rice rat. Implementing effective rodent control measures, such as maintaining clean living environments, sealing entry points, and using rodenticides, can help reduce the risk of human exposure to infected rodents.
Proper hygiene practices can help minimize the risk of Machupo virus exposure. These practices include washing your hands, avoiding contact with ill people, and enclosing your mouth & nose during coughing or sneezing.
When working in areas where the Machupo virus is found, wearing personal protective equipment (PPE) is essential. PPE includes gloves, goggles, and a mask. PPE can help to protect you from exposure to the virus.
There is a vaccine available for the Machupo virus. This vaccine is effective in preventing Bolivian hemorrhagic fever.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
